• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Ophtha folks-How long do we have?

anonymous

Guest
Taking bets as to how long we have at B&L until the axe falls. Who goes first? RDs, ABLs or reps? Please tell me it will be the RD in a he northeast. She is the most useless person in a senior leadership role I’ve ever worked for.
 

<











Similar threads

Replies
10
Views
1K
Novartis
anonymous
Replies
18
Views
3K
Novartis
anonymous
Replies
28
Views
6K
Replies
2
Views
2K